Richelieu Gestion’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$185K Hold
858
0.19% 53
2023
Q4
$222K Hold
858
0.2% 51
2023
Q3
$221K Hold
858
0.21% 49
2023
Q2
$244K Sell
858
-5,953
-87% -$1.77M 0.2% 49
2023
Q1
$1.89M Sell
6,811
-1,647
-19% -$456K 1.71% 35
2022
Q4
$2.34M Buy
8,458
+1,319
+18% +$373K 2.45% 17
2022
Q3
$1.91M Buy
7,139
+6,202
+662% +$1.32M 2.27% 23
2022
Q2
$191K Buy
937
+424
+83% +$86.7K 0.22% 45
2022
Q1
$108K Buy
+513
New +$112K 0.09% 61

Other funds holding BIIB

Richelieu Gestion's BIIB Position: Q1 2024 in Review

Richelieu Gestion held its Biogen (BIIB) position steady in Q1 2024 at 858 shares worth $185K. The position accounts for 0.19% of the portfolio, ranked #53.

Richelieu Gestion first reported a position in BIIB in Q1 2022 and has held it in 9 quarters since. The position peaked at $2.34M in Q4 2022. 954 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • Richelieu Gestion held 858 shares of Biogen worth $185K as of Q1 2024.
  • Richelieu Gestion left its Biogen share count unchanged in Q1 2024.
  • Biogen made up 0.19% of Richelieu Gestion's portfolio in Q1 2024, its #53 holding.
  • Richelieu Gestion first reported a position in Biogen in Q1 2022 and has held it in 9 quarters since.
  • Richelieu Gestion's Biogen position peaked at $2.34M in Q4 2022.
  • 954 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Richelieu Gestion's 13F filing for Q1 2024, filed 15 Apr 2024.